Association of hemoglobin with ambulatory arterial stiffness index in untreated essential hypertensive patients without anemia

Internal Medicine

Volumn 50, Issue 22, 2011, Pages 2759-2765

  Chen, Huimin ^a   Hua, Qi ^a   Hou, Haixia ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Ambulatory arterial stiffness index; Arterial stiffness; Hemoglobin; Hypertension

Indexed keywords

CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; URIC ACID;

ADULT; AGE; AGED; AMBULATORY ARTERIAL STIFFNESS INDEX; ANEMIA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ESSENTIAL HYPERTENSION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREDICTION; PULSE PRESSURE; SMOKING; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ADULT; ANEMIA; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PILOT PROJECTS; VASCULAR STIFFNESS;

EID: 81155153687     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5832     Document Type: Article

References (35)

1. Erikssen G, Thaulow E, Sandvik L, Stormorken H, Erikssen J. Haematocrit: a predictor of cardiovascular mortality? J Intern Med 234: 493-499, 1993.
2. Devereux RB, Drayer JI, Chien S, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 54: 592-595, 1984.
3. Narayan P, Papademetriou V, Wachtell K, et al. Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study. Hypertension 47: 868-873, 2006.
4. Olsen MH, Wachtell K, Beevers G, et al. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. Am Heart J 157: 177-184, 2009.
5. van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 32: 454-460, 2001.
6. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39: 10-15, 2002.
7. Li Y, Wang JG, Dolan E, et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 47: 359-364, 2006.
8. Leoncini G, Ratto E, Viazzi F, et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 48: 397-403, 2006.
9. Garcia-Garcia A, Gomez-Marcos MA, Recio-Rodriguez JI, et al. Relationship between ambulatory arterial stiffness index and subclinical target organ damage in hypertensive patients. Hypertens Res 34: 180-186, 2011.
10. Dolan E, Thijs L, Li Y, et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 47: 365-370, 2006.
11. Hansen TW, Staessen JA, Torp-Pedersen C, et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 24: 2247-2253, 2006.
12. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 17: 151-183, 1999.
13. World Health Organization. Nutritional anaemias: Report of a WHO Scientific Group. Geneva, Switzerland: World Health Organization 1968.
14. Gavish B, Ben-Dov IZ, Bursztyn M. Linear relationship between systolic and diastolic blood pressure monitored over 24 h: assessment and correlates. J Hypertens 26: 199-209, 2008.
15. Gavish B, Ben-Dov IZ, Kark JD, Mekler J, Bursztyn M. The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short-term mortality. Hypertens Res 32: 488-495, 2009.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999.
17. Schillaci G, Parati G, Pirro M, et al. Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension 49: 986-991, 2007.
18. Ben-Dov IZ, Gavish B, Kark JD, Mekler J, Bursztyn M. A modified ambulatory arterial stiffness index is independently associated with all-cause mortality. J Hum Hypertens 22: 761-766, 2008.
19. Fowkes FG, Lowe GD, Rumley A, Lennie SE, Smith FB, Donnan PT. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J 14: 597-601, 1993.
20. Nishikido N, Kobayashi T, Kashiwazaki H. Hematocrit correlates with blood pressure in young male office workers. Ind Health 37: 76-81, 1999.
21. Cinar Y, Demir G, Pac M, Cinar AB. Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens 12: 739-743, 1999.
22. Fossum E, Hoieggen A, Moan A, Nordby G, Velund TL, Kjeldsen SE. Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors. Blood Press 6: 161-165, 1997.
23. Folkow B. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med Suppl 4: 3s-22s, 1978.
24. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP, Lemon DD. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 36: 685-697, 2004.
25. Yu B, Shahid M, Egorina EM, et al. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier. Anesthesiology 112: 586-594, 2010.
26. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73: 411-418, 2009.
27. Bellien J, Favre J, Iacob M, et al. Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans. Hypertension 55: 674-680, 2010.
28. Angermayr B, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J, Fernandez M. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. J Hepatol 44: 1033-1039, 2006.
29. Cao J, Inoue K, Li X, Drummond G, Abraham NG. Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol 41: 1025-1033, 2009.
30. Yu X, Tao W, Jiang F, Li C, Lin J, Liu C. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1. Am J Hypertens 23: 895-903, 2010.
31. Lin R, Fu W, Zhou W, et al. Association of heme oxygenase-1 gene polymorphisms with essential hypertension and blood pressure in the Chinese Han population. Genet Test Mol Biomarkers 15: 23-28, 2011.
32. Durante W, Johnson FK, Johnson RA. Role of carbon monoxide in cardiovascular function. J Cell Mol Med 10: 672-686, 2006.
33. Kazmi WH, Kausz AT, Khan S, et al. Anemia: an early complication of chronic renal insufficiency. Am J Kidney Dis 38: 803-812, 2001.
34. Salisbury AC, Alexander KP, Reid KJ, et al. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 3: 337-346, 2010.
35. Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 10: 22, 2010.